Fisher Asset Management LLC Sells 3,273 Shares of Omnicell, Inc. (NASDAQ:OMCL)

Fisher Asset Management LLC trimmed its position in shares of Omnicell, Inc. (NASDAQ:OMCL) by 1.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 231,590 shares of the company’s stock after selling 3,273 shares during the period. Fisher Asset Management LLC owned approximately 0.50% of Omnicell worth $8,715,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Greenwood Capital Associates LLC increased its stake in Omnicell by 12.9% during the fourth quarter. Greenwood Capital Associates LLC now owns 12,659 shares of the company’s stock valued at $476,000 after acquiring an additional 1,447 shares during the period. Caxton Associates LP bought a new position in Omnicell during the fourth quarter valued at about $2,115,000. Nebula Research & Development LLC bought a new position in Omnicell during the fourth quarter valued at about $891,000. Cadian Capital Management LP bought a new stake in shares of Omnicell in the 4th quarter valued at approximately $2,446,000. Finally, Invenomic Capital Management LP acquired a new position in shares of Omnicell in the 4th quarter worth approximately $3,936,000. 97.70% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Benchmark reissued a “buy” rating and issued a $38.00 target price on shares of Omnicell in a report on Tuesday, April 30th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $42.20.

Omnicell Trading Down 1.6 %

Shares of OMCL opened at $27.46 on Thursday. The stock has a market cap of $1.26 billion, a PE ratio of -59.70, a PEG ratio of 98.97 and a beta of 0.84. Omnicell, Inc. has a 1 year low of $25.69 and a 1 year high of $75.07. The stock has a 50 day simple moving average of $29.45 and a 200-day simple moving average of $30.89. The company has a current ratio of 2.38, a quick ratio of 2.13 and a debt-to-equity ratio of 0.48.

Omnicell (NASDAQ:OMCL) last released its quarterly earnings results on Thursday, May 2nd. The company reported ($0.14) EPS for the quarter, topping analysts’ consensus estimates of ($0.31) by $0.17. The business had revenue of $246.15 million for the quarter, compared to analyst estimates of $235.70 million. Omnicell had a positive return on equity of 2.41% and a negative net margin of 1.91%. On average, sell-side analysts predict that Omnicell, Inc. will post 0.2 EPS for the current fiscal year.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.